EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 32 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $0 | -100.0% | 10 | -100.0% | 0.00% | -100.0% |
| Q1 2016 | $257,000 | -7.6% | 90,000 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $278,000 | -40.1% | 90,000 | -0.0% | 0.01% | -50.0% |
| Q3 2015 | $464,000 | +80.5% | 90,001 | +100.0% | 0.01% | +100.0% |
| Q2 2015 | $257,000 | -36.2% | 45,001 | -0.0% | 0.01% | -37.5% |
| Q1 2015 | $403,000 | – | 45,003 | +1500000.0% | 0.01% | – |
| Q4 2014 | $0 | – | 3 | 0.0% | 0.00% | – |
| Q3 2014 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,265,988 | $12,939,000 | 1.30% |
| Camber Capital Management LP | 1,847,500 | $10,549,000 | 0.72% |
| Cormorant Asset Management, LP | 896,600 | $5,120,000 | 0.68% |
| SOUTHPORT MANAGEMENT, L.L.C. | 50,000 | $286,000 | 0.37% |
| Broadfin Capital, LLC | 775,000 | $4,425,000 | 0.24% |
| BAILARD, INC. | 246,431 | $1,407,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,223,922 | $12,699,000 | 0.06% |
| Lombard Odier Asset Management (USA) Corp | 126,807 | $724,000 | 0.05% |
| ARDSLEY ADVISORY PARTNERS LP | 25,000 | $143,000 | 0.02% |
| Spark Investment Management LLC | 17,900 | $102,000 | 0.01% |